• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science . Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

tetano

Editor, Senior Moderator
Science


. 2020 Oct 20;eabd2985.
doi: 10.1126/science.abd2985. Online ahead of print.
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity


Ludovico Cantuti-Castelvetri[SUP] #[/SUP][SUP] 1 2 [/SUP], Ravi Ojha[SUP] #[/SUP][SUP] 3 [/SUP], Liliana D Pedro[SUP] #[/SUP][SUP] 1 2 [/SUP], Minou Djannatian[SUP] #[/SUP][SUP] 1 2 [/SUP], Jonas Franz[SUP] #[/SUP][SUP] 4 [/SUP], Suvi Kuivanen[SUP] #[/SUP][SUP] 5 [/SUP], Franziska van der Meer[SUP] 4 [/SUP], Katri Kallio[SUP] 3 [/SUP], Tuğberk Kaya[SUP] 1 2 6 [/SUP], Maria Anastasina[SUP] 3 7 [/SUP], Teemu Smura[SUP] 5 [/SUP], Lev Levanov[SUP] 5 [/SUP], Leonora Szirovicza[SUP] 5 [/SUP], Allan Tobi[SUP] 8 [/SUP], Hannimari Kallio-Kokko[SUP] 9 [/SUP], Pamela ?sterlund[SUP] 10 [/SUP], Merja Joensuu[SUP] 11 [/SUP], Fr?d?ric A Meunier[SUP] 11 [/SUP], Sarah J Butcher[SUP] 3 7 [/SUP], Martin Sebastian Winkler[SUP] 12 [/SUP], Brit Mollenhauer[SUP] 13 [/SUP], Ari Helenius[SUP] 14 [/SUP], Ozgun Gokce[SUP] 6 15 [/SUP], Tambet Teesalu[SUP] 3 16 17 [/SUP], Jussi Hepojoki[SUP] 5 18 [/SUP], Olli Vapalahti[SUP] 5 9 19 [/SUP], Christine Stadelmann[SUP] 4 [/SUP], Giuseppe Balistreri[SUP] 20 15 [/SUP], Mikael Simons[SUP] 21 2 22 [/SUP]



Affiliations

Abstract

The causative agent of coronavirus induced disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For many viruses, tissue tropism is determined by the availability of virus receptors and entry cofactors on the surface of host cells. Here, we found that neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, an effect blocked by a monoclonal blocking antibody against NRP1. A SARS-CoV-2 mutant with an altered furin cleavage site did not depend on NRP1 for infectivity. Pathological analysis of human COVID-19 autopsies revealed SARS-CoV-2 infected cells including olfactory neuronal cells facing the nasal cavity positive for NRP1. Our data provide insight into SARS-CoV-2 cell infectivity and define a potential target for antiviral intervention.
 
Back
Top Bottom